Testing aids nicotine-use cessation: Paul Jannetto, Ph.D.
Mar 12, 2024•10 min•Ep. 284
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' nicotine testing benefits patients in substance-use cessation programs and other settings. The serum and urine tests quantify nicotine and various metabolites.
(00:32)
Can you tell us a little bit about yourself and your background?
(01:42)
Can you please provide an overview of substance use disorders, specifically nicotine dependence, and Mayo Clinic's nicotine testing options?
(04:33)
Which patients should have this testing and when should it be performed?
(05:54)
What alternative test options are available and how do these compare?
(06:40)
How are the results used in patient care?
For the best experience, listen in Metacast app for iOS or Android